Remon S. Estfanous

Targeting oxidative stress, proinflammatory cytokines, apoptosis and toll like receptor 4 by empagliflozin to ameliorate bleomycin-induced lung fibrosis

Ahmed M. Kabel, Remon S. Estfanous, Majed Alrobaian · Respiratory Physiology & Neurobiology · 2019 · 40 citations

Inflammation, Fibrosis, Anti-inflammatory +14

RETRACTED: Ameliorative potential of sitagliptin and/or resveratrol on experimentally-induced clear cell renal cell carcinoma

Ahmed M. Kabel, Aliaa Atef, Remon S. Estfanous · Biomedicine & Pharmacotherapy · 2017 · 34 citations · Full text

Chemoprevention Strategy, Renal Pathology, Renal Inflammation +18

Dapagliflozin/Hesperidin Combination Mitigates Lipopolysaccharide-Induced Alzheimer’s Disease in Rats

Maaly A. Abd Elmaaboud, Remon S. Estfanous, Aliaa Atef et al. · Pharmaceuticals · 2023 · 30 citations · Full text

Targeting Oxidative Stress, NLRP3 Inflammasome, and Autophagy by Fraxetin to Combat Doxorubicin-Induced Cardiotoxicity

Ahmed M. Kabel, Samir A. Salama, Almokhtar A. Adwas et al. · Pharmaceuticals · 2021 · 20 citations · Full text

Heart Failure, Doxorubicin Use, Lipid Peroxidation +17

Omarigliptin/galangin combination mitigates lipopolysaccharide-induced neuroinflammation in rats: Involvement of glucagon-like peptide-1, toll-like receptor-4, apoptosis and Akt/GSK-3β signaling

Ahmed M. Kabel, Hany H. Arab, Aliaa Atef et al. · Life Sciences · 2022 · 20 citations

Inflammation, Akt/gsk-3β Signaling, Omarigliptin/galangin Combination +8